Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
AU Stocks

IPX.AX falls 26.33% to A$5.26 on 13 Mar 2026: drivers and outlook

March 13, 2026
5 min read
Share with:

IPX.AX stock dropped 26.33% to A$5.26 at the close on 13 Mar 2026, making IperionX Limited one of the top losers on the ASX today. Trading volume surged to 2,148,094 shares versus an average of 1,048,398, signalling heavy selling pressure after the stock opened at A$5.89 and came from a prior close of A$7.14. The move cut the stock well below its 50‑day average of A$6.68 and left short‑term momentum indicators mixed. We examine valuation, catalysts, and the near‑term outlook for IperionX Limited (IPX.AX) on the ASX

Price action and day drivers for IPX.AX stock

The chief fact today is the -26.33% decline to A$5.26 on 13 Mar 2026. Heavy volume (2,148,094) and a wide intraday range A$5.26–A$5.89 point to forced selling and profit taking after recent gains. Market commentary and secondary reporting, including MarketBeat and Investing.com, highlighted institutional rebalancing and a gap down in related ADR listings as contributors source source.

Sponsored

Fundamentals and valuation: what the numbers show for IPX.AX stock

IperionX Limited (IPX.AX) shows mixed fundamentals: EPS is -0.19 and reported PE is -32.21, reflecting current losses. The company trades at a high price‑to‑book ratio near 15.02 and market capitalisation of approximately A$2.07B. The balance sheet appears liquid with a current ratio of 6.99, but free cash flow per share is negative at -0.0445. These metrics explain why valuation remains sensitive to execution on commercial titanium and mineral sands projects.

Technical snapshot and short‑term signals for IPX.AX stock

Technicals show short‑term weakness but not oversold extremes: RSI sits at 44.66, MACD histogram is positive but small, and ATR is 0.48, signalling elevated volatility. The stock sits below the 50‑day moving average (A$6.68) and near the Bollinger lower band (A$5.35). On‑balance volume has fallen, reinforcing today’s selling bias. Traders will watch the A$5.00–A$5.50 zone for short‑term support.

Meyka AI grade and model forecast for IPX.AX stock

Meyka AI rates IPX.AX with a score out of 100. Score: 60.01 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of A$5.81, a quarterly target of A$6.03, and a 12‑month target of A$8.95. Versus the close at A$5.26, the 12‑month forecast implies an upside of 70.06%. Forecasts are model‑based projections and not guarantees.

Analyst views, institutional flows and sector context for IPX.AX stock

Street coverage is mixed: recent research ranges from Buy ratings with targets near US$51–US$74 on ADR listings to Sell calls. Institutional filings show renewed interest from funds such as VanEck, but ownership remains modest. IPX operates in the Basic Materials / Industrial Materials sector; sector pressures and commodity cycles affect demand for titanium feedstocks. Investors should watch upcoming earnings on 17 Mar 2026 and any Stony Creek or Titan project updates.

Risks, catalysts and what to watch next for IPX.AX stock

Key risks include continued negative EPS, high valuation multiples versus book value, and execution risk on commercial scale‑up. Near‑term catalysts that could stabilise the stock are strong quarterly results, confirmation of supply contracts, or positive permitting updates on mineral sands assets. Watch volume, ADR flows, and guidance out of the next earnings announcement for direction.

Final Thoughts

IPX.AX stock slipped 26.33% to A$5.26 on 13 Mar 2026 after heavy volume and headline flows on ADR and ASX listings. Fundamentals show a negative EPS (-0.19) and a stretched price‑to‑book ratio (15.02), while the balance sheet signals liquidity with a current ratio of 6.99. Meyka AI’s forecast model projects a monthly price of A$5.81, a quarterly target of A$6.03, and a 12‑month target of A$8.95, implying a 12‑month upside of 70.06% versus today’s close. That upside reflects the model’s view of commercialisation potential in titanium and mineral sands, but it sits against real execution risk and elevated volatility (ATR 0.48). As an AI‑powered market analysis platform, Meyka AI flags a B / HOLD grade and recommends monitoring earnings due 17 Mar 2026, institutional positioning, and any supply‑contract announcements before re‑rating positions. Forecasts are model‑based projections and not guarantees.

FAQs

Why did IPX.AX stock fall sharply on 13 Mar 2026?

The drop reflected heavy volume, a gap down in related ADR listings, and short‑term profit taking. Market flows and institutional rebalancing amplified selling pressure ahead of the next earnings date on 17 Mar 2026.

What is Meyka AI’s view on IPX.AX stock?

Meyka AI rates IPX.AX 60.01/100 (Grade B, HOLD). The model highlights upside from commercialisation but flags execution risk and stretched valuation metrics.

What are the key financial metrics for IperionX (IPX.AX)?

Key metrics: price A$5.26, EPS -0.19, PE -32.21, PB 15.02, market cap about A$2.07B, current ratio 6.99 and shares outstanding 337,595,858.

What price targets and outlook exist for IPX.AX stock?

Meyka AI’s forecast model projects monthly A$5.81, quarterly A$6.03, and 12‑month A$8.95, implying about 70.06% upside to the 12‑month figure from today’s close. Forecasts are projections and not guarantees.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)